Results
1 -
5 of
5Okuzumi et al..
Inhibitor hijacking of Akt activation, Nature Chemical Biology, 2009 AKT, Cancer Therapeutic Targets mTORC1?S6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome mice, Cellular and Molecular Life Sciences mTORC2 in the dorsomedial striatum of mice contributes to alcohol-dependent F-Actin polymerization, structural modifications, and consumption, Neuropsychopharmacology TORC2: a novel target for treating age-associated memory impairment, Scientific Reports